Detalles de la búsqueda
1.
Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas.
Br J Cancer
; 129(2): 291-300, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37208512
2.
A phase I dose-escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC-223 in patients with advanced solid tumors or multiple myeloma.
Cancer
; 121(19): 3481-90, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26177599
3.
Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2.
JCO Precis Oncol
; 8: e2300494, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38865673
4.
Drug interactions and the pharmacist: focus on everolimus.
Ann Pharmacother
; 47(7-8): 1055-63, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23757385
5.
A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies.
Cancer Res Commun
; 2(7): 570-576, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36923283
6.
Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies.
J Clin Oncol
; 35(11): 1231-1239, 2017 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28221861
7.
Differential Toxicity in Patients with and without DNA Repair Mutations: Phase I Study of Carboplatin and Talazoparib in Advanced Solid Tumors.
Clin Cancer Res
; 23(21): 6400-6410, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28790114
8.
Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.
J Clin Oncol
; 33(9): 1060-6, 2015 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25605849
9.
Impact of patient ethnicity on the metabolic and immunologic effects of PI3K-mTOR pathway inhibition in patients with solid tumor malignancies.
Cancer Chemother Pharmacol
; 74(2): 359-65, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24934865
Resultados
1 -
9
de 9
1
Próxima >
>>